| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | Director | Common Stock | 5,703 | $258,003 | $45.24 | 29 May 2025 | Direct |
| Mirum Pharmaceuticals, Inc. | Director | Restricted Stock Units | 3,977 | $146,453 | $25.68 | 29 May 2025 | Direct |
| Mirum Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 6,268 | 29 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MIRM | Mirum Pharmaceuticals, Inc. | 29 May 2025 | 4 | $0 | 4 | Director | 02 Jun 2025, 19:34 |
| MIRM | Mirum Pharmaceuticals, Inc. | 05 Jun 2024 | 2 | $0 | 4 | Director | 07 Jun 2024, 18:23 |
| MIRM | Mirum Pharmaceuticals, Inc. | 12 Jun 2023 | 1 | $0 | 4 | Director | 14 Jun 2023, 17:56 |
| MIRM | Mirum Pharmaceuticals, Inc. | 19 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 20:26 |
| MIRM | Mirum Pharmaceuticals, Inc. | 19 Dec 2022 | 0 | $0 | 3 | Director | 19 Dec 2022, 20:22 |